ADVERTISEMENT
Executive Changes
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
A couple of months after leaving Hikma, former Custopharm CEO and Hikma injectables chief Bill Larkins has been named as the new president of Par Health’s injectables business.
As Denmark’s Orifarm announced the appointment of Jutta Schnirring-Mayer as chief business development and portfolio strategy officer – the latest in a line of management changes under new CEO Mads Fink Eriksen – the firm set out its ambitions to expand its European generics business.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Speaking exclusively to Generics Bulletin, Alvotech’s founder Robert Wessman explains why the company’s leadership split and Lisa Graver’s Iceland-based appointment as CEO mark a pivotal moment in its operational evolution.
Kicking off 2026 with a raft of changes, Medicines for Europe has appointed Zentiva CEO Steffen Saltofte as president while the IGBA has named CGPA head Jim Keon as chair for 2026. Meanwhile, Accord has named a new UK country head as ANI, Olpha, Outlook and Stada have announced management updates.
Alvotech has unveiled a planned leadership transition, with founder and chairman Róbert Wessman handing the chief executive role to long-time collaborator Lisa Graver as the biosimilars specialist prepares for its next phase of growth.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.